.Attributes Medication, Released online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective asks for incorporation of people with MASLD and also measurement of liver outcomes in cardio-- renal-- metabolic trials, when data propose mechanistically tenable benefits as well as scientific safety and security-- and also lays out factors for trial style as well as regulative approval.